Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
Someone this morning mentioned iqai being like rms which I disregarded instantly but may of been hasty. Both companies have ground breaking tech and are awaiting order however one is valued at £45million and the other at £20million so is one over valued or is one under valued?
Is that going by how lse post them? I think the price has been jumped around to hide what trades are what personally and all of them 100ks are in fact buys. Just my opinion.
£1000 per test per patient? Pure guess & sounds a lot but half the price of the current procedure. An upfront fee and then a pay per patient fee maybe? Or just a subscription maybe. £200k per hospital per year? All guesswork but a start point